Article

Investigation of the Role of CpG Methylation in Epithelial Mesenchymal Transition Master Genes in a Chemoresistant Ovarian Cancer Cell line

2021-06-02

Abstract excerpt

Ovarian cancer is one of the commonly diagnosed cancers among women. Chemoresistant is an essential reason for treatment failure and high mortality. Emerging evidence connects epithelial mesenchymal transition (EMT) like changes and acquisition of chemoresistance in cancer. DNA methylation influences cellular processes including EMT. Here, we investigate EMT like changes in cisplatin-resistant A2780 ovarian cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2f890726-b57a-55ef-9fa1-832261dd3c7d
DOI: 10.21203/rs.3.rs-579729/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Investigation of the Role of CpG Methylation in Epithelial Mesenchymal Transition Master Genes in a Chemoresistant Ovarian Cancer Cell lineDOI 10.21203/rs.3.rs-579729/v1Read

DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian CancerSemantic proximity Read

TET1 promotes cisplatin‐resistance via demethylating the vimentin promoter in ovarian cancerSemantic proximity Read

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell linesSemantic proximity Read

Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersSemantic proximity Read

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancerSemantic proximity Read

Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samplesSemantic proximity Read

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancerSemantic proximity Read

Epithelial–mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCCSemantic proximity Read

Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)Semantic proximity Read

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerSemantic proximity Read

Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer.Semantic proximity Read

Biomarkers of drug resistance in ovarian cancerSemantic proximity Read